Todd C. Brady
2021
In 2021, Todd C. Brady earned a total compensation of $3.5M as President and Chief Executive Officer at Aldeyra Therapeutics, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,903 |
|---|---|
| Option Awards | $2,050,361 |
| Salary | $547,097 |
| Stock Awards | $545,908 |
| Other | $11,400 |
| Total | $3,455,670 |
Brady received $2.1M in option awards, accounting for 59% of the total pay in 2021.
Brady also received $300.9K in non-equity incentive plan, $547.1K in salary, $545.9K in stock awards and $11.4K in other compensation.
Rankings
In 2021, Todd C. Brady's compensation ranked 3,876th out of 12,415 executives tracked by ExecPay. In other words, Brady earned more than 68.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,876 out of 12,415 | 69th |
Division Manufacturing | 1,589 out of 5,505 | 71st |
Major group Chemicals And Allied Products | 651 out of 2,375 | 73rd |
Industry group Drugs | 579 out of 2,096 | 72nd |
Industry Pharmaceutical Preparations | 405 out of 1,546 | 74th |
Source: SEC filing on April 25, 2022.
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2021.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019